RxDoctor Payments DataLook up a doctor →

Latia Butts

Nurse Practitioner · Grenada, MSNPI 1164731931

Payments from drug & device makers

$9,673in general payments, 2019–2025

Across 509 payments — averaging $19.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$751
  • Eisai Inc.$730
  • Merck$621
  • Gilead$618
  • Pfizer$601
  • Daiichi Sankyo Inc.$586
  • plus $6K from 50 others

What the payments were for

  • Food & beverage$9,28896%
  • Education$3844%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,673 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$21,244
Medicare patients
193
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PomalystPomalidomide30$690,453
PromactaEltrombopag Olamine26$338,923
IbrancePalbociclib16$252,390
VenclextaVenetoclax25$250,197
CalquenceAcalabrutinib Maleate15$228,121
VerzenioAbemaciclib14$191,524
ImbruvicaIbrutinib13$188,322
Abiraterone Acetate21$75,532
EliquisApixaban38$26,275
OxycontinOxycodone Hcl18$19,986
XareltoRivaroxaban17$8,877
Imatinib Mesylate13$3,662
Exemestane13$1,745
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen90$1,322
Morphine Sulfate ErMorphine Sulfate12$1,052

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
E.r. Squibb & Sons, L.L.C.Pomalyst$560$690,45330 claims
NovartisPromacta$751$338,92326 claims
PfizerIbrance, Eliquis$601$278,66554 claims
AbbVieVenclexta$332$250,19725 claims
AstraZenecaCalquence$488$228,12115 claims
Lilly USA, LLCVerzenio, Olanzapine$425$191,56226 claims
Johnson & JohnsonXarelto$234$8,87717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Grenada

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →